MTSR (Metsera, Inc.) רווח למניה בארבעת הרבעונים האחרונים

Metsera Inc capitalization relies on the commercialization of innovative peptides for obesity treatment. The current YoY ttm net income per share growth on this GURU.Markets platform chart reflects price action where the 0.00 indicator expresses the state of the metric. Partnerships with research centers and manufacturing plants are accelerating business development, while a stable operating environment is ensured by minimal geopolitical influence.

This indicator measures the annual growth of net income per share over the last twelve months, reflecting the scaling speed of business profitability. Analyzing the current EPS YoY TTM growth rate allows for stress-testing the capital resilience of Metsera Inc. (MTSR) against Fed rates, assessing the ability of innovative obesity drugs to generate profit in a high-cost borrowing environment.